Literature DB >> 1856741

Assessment of proliferative potential in gliomatosis cerebri.

A Hara1, N Sakai, H Yamada, T Tanaka, H Mori.   

Abstract

The proliferative potential of neoplastic cells in two cases of gliomatosis cerebri was investigated by a combined staining technique, a one-step silver colloid method for nucleolar organizer region-associated protein (AgNOR) and immunohistochemistry for fibrillary acidic protein (GFAP). The neoplastic cells in the two cases had an abnormal shape and showed positive GFAP immunostaining in their cytoplasm. The numbers of AgNORs were counted in central and peripheral lesions of the neoplastic field in each case. The mean AgNOR scores in neoplastic cells were almost the same as those of nonneoplastic astrocytes in both the central and the peripheral lesions. These values were almost equal to the AgNOR score of low-grade gliomas. These findings indicate that gliomatosis cerebri has an invasive character in the central nervous system and often shows a malignant tendency, but its proliferative potential is significantly lower than that of high-grade gliomas.

Entities:  

Mesh:

Year:  1991        PMID: 1856741     DOI: 10.1007/bf00315685

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.

Authors:  A Hara; H Hirayama; N Sakai; H Yamada; T Tanaka; H Mori
Journal:  Surg Neurol       Date:  1990-05

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

Review 3.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

4.  Nucleolar organiser regions in fibrous proliferations of childhood and infantile fibrosarcoma.

Authors:  M J Egan; F Raafat; J Crocker; K Smith
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

5.  Further evidence that phosphoprotein C23 (110 kD/pI 5.1) is the nucleolar silver staining protein.

Authors:  R L Ochs; H Busch
Journal:  Exp Cell Res       Date:  1984-05       Impact factor: 3.905

6.  Argyrophilic nuclear and nucleolar proteins of Xenopus laevis oocytes identified by gel electrophoresis.

Authors:  M A Williams; J A Kleinschmidt; G Krohne; W W Franke
Journal:  Exp Cell Res       Date:  1982-02       Impact factor: 3.905

7.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

8.  Gliomatosis cerebri. Report of four cases and review of the literature.

Authors:  J R Couch; S A Weiss
Journal:  Neurology       Date:  1974-06       Impact factor: 9.910

9.  Diffuse cerebrospinal gliomatosis presenting as motor neuron disease for two years.

Authors:  M Schmidbauer; C Müller; I Podreka; B Mamoli; E Sluga; L Deecke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

10.  Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry.

Authors:  T Tanaka; T Takeuchi; A Nishikawa; T Takami; H Mori
Journal:  Jpn J Cancer Res       Date:  1989-11
View more
  2 in total

1.  Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.

Authors:  C Mawrin; V Aumann; E Kirches; R Schneider-Stock; C Scherlach; S Vogel; U Mittler; K Dietzmann; G Krause; S Weis
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.